Novartis Pharma AG 13D and 13G filings for Precision BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-06 4:01 pm Unchanged | 2025-06-30 | 13G | Precision BioSciences, Inc. DTIL | Novartis Pharma AG | 413,581 3.700% | 0 (Unchanged) | Filing |
| 2025-02-12 5:00 pm Purchase | 2024-12-31 | 13G | Precision BioSciences, Inc. DTIL | Novartis Pharma AG | 413,581 5.400% | 413,581 (New Position) | Filing |